【ChiCTR1900027201】EFFECTIVENESS OF DISTANCE INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS IN KHYBER PUKHTUNKHWA, PAKISTAN
ChiCTR1900027201
正在进行
/
/
/
2019-11-05
/
/
患病儿童的远程综合管理
EFFECTIVENESS OF DISTANCE INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS IN KHYBER PUKHTUNKHWA, PAKISTAN
EFFECTIVENESS OF dIMCI TRAINING IN KHYBER PAKHTUNKHWA, PAKISTAN
1. To evaluate the effectiveness of distance IMCI training regarding improvement in case management skills of health care providers compared to the standard IMCI training; 2. To explore perceptions of health care providers regarding distance and standard IMCI trainings.
随机平行对照
其它
All eligible health facilities will be entered into a computer software and required number of health facilities i.e. 26 will be selected through simple random sampling by the Principal investigator. Then these facilities will be randomly assigned to TWO equal groups (13+13) using the same software by a sec
Only at the level of evaporators during assessment.Training participants cant be blinded to the type of training.
Monthly Salary of the Principal Investigator
/
13
/
2019-07-01
2020-05-31
/
All the First Level Care Facilities(HCFs) of Abbottabad having at least 4 under-five consultations per day will be included in the study.；
请登录查看Once, HCFs are identified under inclusion criteria, if there is no Health Care Provider(HCP) or there is a trained HCP in a facility, that facility will be excluded from the study. Informed consent forms will be sent to all eligible HCPs. If ALL eligible HCPs i.e. untrained HCPs of a health facility refuse to participate in the study, that health facility will be excluded from trainings, assessment and analysis but will be reported.；
请登录查看Self sponsored
/
Self sponsored的其他临床试验
巴基斯坦卫生部的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04